Insider Buying: CRYO-CELL International, Inc. (CCEL) Director Buys $14,700.00 in Stock

CRYO-CELL International, Inc. (OTCMKTS:CCEL) Director Brian L. Sheehy bought 2,100 shares of the firm’s stock in a transaction that occurred on Thursday, January 10th. The stock was purchased at an average cost of $7.00 per share, with a total value of $14,700.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

OTCMKTS:CCEL opened at $7.25 on Monday. CRYO-CELL International, Inc. has a 1-year low of $6.03 and a 1-year high of $9.98. The firm has a market capitalization of $54.17 million, a P/E ratio of 25.00 and a beta of 0.10.

CRYO-CELL International (OTCMKTS:CCEL) last released its quarterly earnings data on Monday, October 15th. The company reported $0.03 EPS for the quarter. CRYO-CELL International had a negative net margin of 3.93% and a negative return on equity of 16.83%. The firm had revenue of $7.87 million during the quarter.

WARNING: “Insider Buying: CRYO-CELL International, Inc. (CCEL) Director Buys $14,700.00 in Stock” was published by WKRB News and is the property of of WKRB News. If you are reading this piece on another site, it was stolen and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.wkrb13.com/2019/01/14/insider-buying-cryo-cell-international-inc-ccel-director-buys-14700-00-in-stock.html.

CRYO-CELL International Company Profile

Cryo-Cell International, Inc engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases.

See Also: Why is insider trading harmful?

Insider Buying and Selling by Quarter for CRYO-CELL International (OTCMKTS:CCEL)

Receive News & Ratings for CRYO-CELL International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRYO-CELL International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply